0 items

in your cart
$0.00

Prescription Drug Search

Product Request Form

Jevtana is currently not available.

Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Jevtana becomes available, please fill out the form below.

Name:
Email:

*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about ExpressMedsCanada.com

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Jevtana:

  • Algeria
  • Aruba
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Brazil
  • Cayman Islands
  • Chile
  • Ecuador
  • Estonia
  • European Union
  • Fiji
  • Finland
  • Germany
  • Guatemala
  • India
  • Iraq
  • Ireland
  • Italy
  • Jamaica
  • Lebanon
  • Monaco
  • Netherlands Antilles
  • New Zealand
  • Norway
  • Poland
  • Romania
  • Russian Federation
  • Slovenia
  • South Africa
  • Switzerland
  • Thailand
  • Tonga
  • Turkey
  • Ukraine
  • United Kingdom, UK
  • United States, US
  • Uzbekistan
  • Vanuatu
View All Countries

Latest news releases on Jevtana:

Cabazitaxel can offer an advantage in certain patients - medicalxpress.com

Cabazitaxel (trade name: Jevtana) has been approved since March 2011 in men with metastatic prostate cancer who no longer respond to conventional therapy with hormone blockers and have already been pre-treated with the cytostatic drug docetaxel.

Anger as NHS deem prostate cancer drug Cabazitaxel 'too expensive' - The Independent

Cabazitaxel, which is marketed as Jevtana, can extends the life of late-stage patients by an average of three months. The National Institute for Health and Clinical Excellence (Nice), which decides which drugs should be offered on the NHS, today confirmed ...

Disappointment for Men With Advanced Prostate Cancer As Life-Extending Drug[1]Refused by NICE - Yahoo Finance

Warning of an emerging 'postcode lottery' for men with advanced prostate cancer as NICE upholds its decision not to approve JEVTANA [®▼] (cabazitaxel) for use on the NHS Dr Jasmin Hussein, Oncology Medical Manager, Sanofi UK comments ...

UK cost body backs Botox for some migraine patients - Reuters UK

SANOFI'S JEVTANA REBUFFED In a separate statement, NICE confirmed its decision not to recommend use of Sanofi's prostate cancer drug Jevtana on Britain's state health service, given its limited ability to extend life, its side effects and its cost.

Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 5 - Seekingalpha.com

On May 16, 2012, Sanofi announced abstracts spanning the company's innovative marketed and late-stage development compounds Zaltrap (aflibercept), Jevtana (cabazitaxel), SAR302503 (JAK2 inhibitor) and ombrabulin will be featured at the 2012 American ...

Dendreon Management Presents at Bank of America Merrill Lynch 2012 Health Care Conference (Transcript) - Seekingalpha.com

But currently the drug in the space along with Docetaxel Taxotere chemotherapeutic regimen, and you’ve seen Jevtana has been approved as Zytiga for the chemo refractory. I think that you will see Zytiga data coming out and we do expect to see that ...

Customer Service
1-866-799-3435 - Use Discount Code 7500 | Contact Form
Copyright © 2012 ExpressMedsCanada.com All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK